This inventor holds 1 USPTO granted patent. Top assignee: Daiichi Seiyaku Co., Ltd.. Active years: 1986.
Company Filing History:
Years Active: 1986
Title: Morihiro Kohno: Innovator in Mannoglucan Derivatives
Introduction
Morihiro Kohno is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of mannoglucan derivatives. His work focuses on the antitumor activity of these derivatives, which have potential applications in medical treatments.
Latest Patents
Morihiro Kohno holds a patent for mannoglucan derivatives. This patent describes mannoglucan derivatives wherein from about 2 to 51 per 100 of side chain α-D-mannopyranosyl residues of mannoglucan have been cleaved and reduced to polyhydroxy residues. These derivatives possess antitumor activity with reduced pyrogenicity, showcasing their potential in therapeutic applications.
Career Highlights
Kohno is associated with Daiichi Seiyaku Co., Ltd., a company known for its commitment to pharmaceutical innovation. His work at the company has allowed him to explore and develop new compounds that can contribute to cancer treatment.
Collaborations
Throughout his career, Morihiro Kohno has collaborated with esteemed colleagues such as Kazuhiro Inoue and Hidemasa Ogawa. These collaborations have fostered a productive environment for research and development in the field of biochemistry.
Conclusion
Morihiro Kohno's contributions to the field of mannoglucan derivatives highlight his innovative spirit and dedication to advancing medical science. His work continues to inspire future research in antitumor therapies.